{"transactions":[{"id":743246,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T22:56:14.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) June 9, 2027 or (ii) the date of the next annual meeting of the Corporation's stockholders."}],"balance_after":22000,"derivative":{"exercise_price":3.22,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001193125-26-266229","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000119312526266229/ownership.xml","form_type":"4"}},{"id":1118033,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-10T00:16:29.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) June 9, 2026 or (ii) the date of the next annual meeting of the Corporation's stockholders."}],"balance_after":22000,"derivative":{"exercise_price":2.37,"expiration_date":"2035-06-08","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0000950170-25-084014","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000095017025084014/ownership.xml","form_type":"4"}},{"id":1142911,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:39:32.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $1.92 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date.  Under the terms of the stock option award repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The \"Retention Period\", through which the Reporting Person must remain in service to the Issuer, commenced on the Repricing Date and ends upon the earliest of (i) the one-year anniversary of the Repricing Date, (ii) a Sale Event (as defined in the 2018 Plan and 2019 Plan, as applicable) and (iii) the termination of the Reporting Person's Service Relationship (as defined in the 2018 Plan and 2019 Plan, as applicable) due to the Reporting Person's death or disability."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":22000,"derivative":{"exercise_price":1.92,"expiration_date":"2034-06-02","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0000950170-25-074824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000095017025074824/ownership.xml","form_type":"4"}},{"id":1142910,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:39:32.000Z","date":"2025-05-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.01,"expiration_date":"2034-06-02","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0000950170-25-074824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000095017025074824/ownership.xml","form_type":"4"}},{"id":1142909,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:39:32.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $1.92 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date.  Under the terms of the stock option award repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The \"Retention Period\", through which the Reporting Person must remain in service to the Issuer, commenced on the Repricing Date and ends upon the earliest of (i) the one-year anniversary of the Repricing Date, (ii) a Sale Event (as defined in the 2018 Plan and 2019 Plan, as applicable) and (iii) the termination of the Reporting Person's Service Relationship (as defined in the 2018 Plan and 2019 Plan, as applicable) due to the Reporting Person's death or disability."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":22000,"derivative":{"exercise_price":1.92,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0000950170-25-074824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000095017025074824/ownership.xml","form_type":"4"}},{"id":1142908,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:39:32.000Z","date":"2025-05-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":11.18,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0000950170-25-074824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000095017025074824/ownership.xml","form_type":"4"}},{"id":1142907,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:39:32.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $1.92 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date.  Under the terms of the stock option award repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The \"Retention Period\", through which the Reporting Person must remain in service to the Issuer, commenced on the Repricing Date and ends upon the earliest of (i) the one-year anniversary of the Repricing Date, (ii) a Sale Event (as defined in the 2018 Plan and 2019 Plan, as applicable) and (iii) the termination of the Reporting Person's Service Relationship (as defined in the 2018 Plan and 2019 Plan, as applicable) due to the Reporting Person's death or disability."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":22000,"derivative":{"exercise_price":1.92,"expiration_date":"2031-05-31","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0000950170-25-074824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000095017025074824/ownership.xml","form_type":"4"}},{"id":1142906,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:39:32.000Z","date":"2025-05-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":11,"expiration_date":"2031-05-31","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0000950170-25-074824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000095017025074824/ownership.xml","form_type":"4"}},{"id":1142905,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:39:32.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":46428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $1.92 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date.  Under the terms of the stock option award repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The \"Retention Period\", through which the Reporting Person must remain in service to the Issuer, commenced on the Repricing Date and ends upon the earliest of (i) the one-year anniversary of the Repricing Date, (ii) a Sale Event (as defined in the 2018 Plan and 2019 Plan, as applicable) and (iii) the termination of the Reporting Person's Service Relationship (as defined in the 2018 Plan and 2019 Plan, as applicable) due to the Reporting Person's death or disability."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":46428,"derivative":{"exercise_price":1.92,"expiration_date":"2029-02-18","underlying":"Common Stock","underlying_shares":46428},"source":{"system":"sec-edgar","filing":"0000950170-25-074824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000095017025074824/ownership.xml","form_type":"4"}},{"id":1142904,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:39:32.000Z","date":"2025-05-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":46428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":6.3,"expiration_date":"2029-02-18","underlying":"Common Stock","underlying_shares":46428},"source":{"system":"sec-edgar","filing":"0000950170-25-074824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000095017025074824/ownership.xml","form_type":"4"}},{"id":1492507,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-04T23:21:13.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) June 3, 2025 or (ii) the date of the next annual meeting of the Corporation's stockholders."}],"balance_after":22000,"derivative":{"exercise_price":10.01,"expiration_date":"2034-06-02","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0000950170-24-068992","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000095017024068992/ownership.xml","form_type":"4"}},{"id":1502141,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-24T20:14:32.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":67000,"derivative":{"exercise_price":3.28,"exercise_date":"2024-05-23","expiration_date":"2034-05-23","underlying":"Common Shares","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001447028-24-000055","document":"wk-form4_1716581649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000144702824000055/wk-form4_1716581649.xml","form_type":"4"}},{"id":1870146,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-02T11:30:09.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) June 1, 2024 or (ii) the date of the next annual meeting of the Corporation's stockholders."}],"balance_after":22000,"derivative":{"exercise_price":11.18,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0000899243-23-014331","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000089924323014331/doc4.xml","form_type":"4"}},{"id":1876668,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-26T20:27:54.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 24, 2023, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":55000,"derivative":{"exercise_price":2.56,"exercise_date":"2023-05-24","expiration_date":"2033-05-24","underlying":"Common Shares","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001447028-23-000048","document":"wk-form4_1685132843.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000144702823000048/wk-form4_1685132843.xml","form_type":"4"}},{"id":2244986,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2022-06-03T20:45:48.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (1) June 1, 2023 or (2) the date of the next annual meeting of the Corporation's stockholders."}],"balance_after":22000,"derivative":{"exercise_price":1.28,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0000899243-22-020995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000089924322020995/doc4.xml","form_type":"4"}},{"id":2255379,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-26T20:19:19.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 25, 2022, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":41000,"derivative":{"exercise_price":2.25,"exercise_date":"2022-05-25","expiration_date":"2032-05-25","underlying":"Common Shares","underlying_shares":41000},"source":{"system":"sec-edgar","filing":"0001447028-22-000038","document":"wf-form4_165359633960254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000144702822000038/wf-form4_165359633960254.xml","form_type":"4"}},{"id":2679481,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-06-07T20:25:24.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on June 3, 2021, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options are fully vested and exercisable as of the date of the grant."}],"balance_after":22000,"derivative":{"exercise_price":2.95,"exercise_date":"2021-06-03","expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001447028-21-000043","document":"wf-form4_162309750584527.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000144702821000043/wf-form4_162309750584527.xml","form_type":"4"}},{"id":2683562,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2021-06-03T20:30:52.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (1) June 1, 2022 or (2) the date of the next annual meeting of the Corporation's stockholders."}],"balance_after":22000,"derivative":{"exercise_price":11,"expiration_date":"2031-05-31","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0000899243-21-021792","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000089924321021792/doc4.xml","form_type":"4"}},{"id":3129255,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-06-01T21:03:22.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 28, 2020, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options are fully vested and exercisable as of the date of the grant."}],"balance_after":22000,"derivative":{"exercise_price":2.16,"exercise_date":"2020-05-28","expiration_date":"2030-05-28","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001447028-20-000068","document":"wf-form4_159104538438792.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000144702820000068/wf-form4_159104538438792.xml","form_type":"4"}},{"id":3433363,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-08-20T20:15:59.000Z","date":"2019-08-17","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on August 16, 2019, the trading day immediately preceding the date of the grant."}],"balance_after":22000,"derivative":{"exercise_price":1.5,"exercise_date":"2019-08-17","expiration_date":"2029-08-17","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001447028-19-000051","document":"wf-form4_156633214408707.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000144702819000051/wf-form4_156633214408707.xml","form_type":"4"}},{"id":3884217,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-06-26T00:56:47.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22000,"derivative":{"exercise_price":6.75,"exercise_date":"2018-06-19","expiration_date":"2028-06-19","underlying":"Common Shares","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001140361-18-029854","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000114036118029854/doc1.xml","form_type":"4"}},{"id":4274669,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39690,"kind":"person","name":"HENRIQUES RICHARD C JR","position":1,"cik":"0001181178","reported_name":"HENRIQUES RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option Grant (Right to Buy)","published_at":"2017-06-22T21:01:31.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22000,"derivative":{"exercise_price":3.55,"exercise_date":"2017-06-21","expiration_date":"2027-06-21","underlying":"Common Shares","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001140361-17-025884","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181178/000114036117025884/doc1.xml","form_type":"4"}}]}